Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Does The Market Size Analysis Show For The Global Biomarkers Market?
The biomarkers market has seen rapid growth over the years with the market size increasing from $68.77 billion in 2024 to an estimated $78.14 billion in 2025, representing a compound annual growth rate (CAGR) of 13.6%. The historic growth can be attributed to advancements in genomics and proteomics technologies, increased prevalence of chronic diseases, a growing emphasis on personalized medicine, rising demand for companion diagnostics, and the expansion of applications in drug development.
The biomarkers market is projected to continue this trend of rapid growth, anticipated to reach $135.14 billion by 2029, growing at a CAGR of 14.7%. Key drivers for this forecasted growth include a growing focus on early disease detection and prevention, the expansion of biomarkers in oncology and immunotherapy, increasing investment in precision medicine initiatives and the rise of liquid biopsy as a non-invasive biomarker detection method. The emerging trends during this period include the development of multi-biomarker panels, emergence of exosome-based biomarkers, adoption of point-of-care biomarker testing, integration of real-world data in biomarker research, and exploration of microbiome-based biomarkers.
Get Your Free Sample of The Global Biomarkers Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp
What’s Driving Growth In The Biomarker Market?
Increasing heart diseases are expected to propel the growth of the biomarkers market in the projected period. The application of biomarkers in the diagnosis of heart disease patients has escalated significantly in recent years, with natriuretic peptides being the most used. The rise in heart diseases will inevitably drive the demand for biomarkers.
How Is The Biomarkers Market Segmented?
The biomarkers market is segmented by:
1) Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) Type: Biomarker Of Exposure, Biomarker Of Diseases
4) Audience: Pharmaceutical Companies, Government and Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Who Are The Major Players In The Biomarkers Market?
Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.
What Are The Emerging Trends In Biomarkers Market Landscape?
Companies within the biomarker market are focusing on the development of innovative solutions. This includes the creation of novel biological markers through collaborative research, technology integration, and strong clinical validation. For instance, Genialis, a US-based computational precision medicine company, launched a first-in-class biomarker in September 2024 to enhance the predictive accuracy for patient responses to KRAS inhibitors.
Which Region Will Emerge As The Fastest-Growing In The Biomarkers Market?
In 2024, North America was the largest region in the biomarkers market, with Asia-Pacific predicted to be the fastest-growing region in the near future. Other regions covered include Western Europe, Eastern Europe, South America, Middle East, and Africa.
What Does The Biomarkers Market Report 2025 Offer?
Biomarkers refer to a biological molecule that is a marker for a condition, disease, or aberrant process and can be discovered in tissues, body fluids, or blood. They can determine how well the body responds to a disease or condition’s treatment, thus having a clinical role in narrowing or guiding treatment decisions. The Biomarkers Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485
About The Business Research Company
Learn More About the Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
